Following treatment with EVs rich in Cav-1 derived from breast cancer (BC), the expression of extracellular matrix (ECM) component proteins such as emilin1, nidogen, TnC, and FN increases in lung fibroblasts. This evidence concerns the gene CAV1 and breast cancer.